Literature DB >> 1500277

Intravenous nutritional support and the surgeon: where next?

D J Hehir1, T F Gorey.   

Abstract

Over the past twenty five years the development of total parenteral nutrition has in many ways revolutionised the practice of surgery. It has enhanced survival in otherwise high mortality operations such as oesophageal surgery, especially with anastomotic complications. It has changed significantly the management of fistulae, either post operative or associated with diseases such as Crohn's enteritis. Here a basic general principle is applied--that a fistula will close if there is no distal obstruction and the throughput can be diminished. This can be achieved by withholding oral feeding and using the parenteral route. It has allowed survival in the short gut syndrome from whatever cause and it is interesting to see the degree of "intestinal adaptation" that occurs once the first critical year is survived with the help of intravenous nutrition. The assessment of nutritional status is difficult and while the level of serum albumin may be taken as a clinical standard, it is obvious that many patients survive extensive surgery with low albumin levels and also that there appears to be a lag period to the restoration of albumin levels, even with otherwise successful nutritional support and with other parameters being satisfactory. Even complex formulae using a combination of laboratory and antropometric parameters is not fully satisfactory as an absolute assessment of nutritional status. It is now interesting to see that nutrition can affect both immune competence and even carcinogenesis. The lipid element in intravenous nutrition may cause dysfunction of immunity and vitamin status, gastric and platelet function with impaired oxygen diffusion leading to increased wedge pressures.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500277     DOI: 10.1007/bf02996202

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  40 in total

1.  Energy expenditures of mechanically ventilated nonsurgical patients.

Authors:  S B Liggett; A D Renfro
Journal:  Chest       Date:  1990-09       Impact factor: 9.410

Review 2.  Metabolic response to sepsis and trauma.

Authors:  R G Douglas; J H Shaw
Journal:  Br J Surg       Date:  1989-02       Impact factor: 6.939

3.  Nutrition in the critically ill.

Authors:  D J Hehir; D M Phelan
Journal:  Ir Med J       Date:  1992-03

4.  Perioperative total parenteral nutrition in surgical patients.

Authors: 
Journal:  N Engl J Med       Date:  1991-08-22       Impact factor: 91.245

5.  Effects of intravenous fat emulsion on respiratory failure.

Authors:  T L Hwang; S L Huang; M F Chen
Journal:  Chest       Date:  1990-04       Impact factor: 9.410

Review 6.  Perioperative parenteral nutrition: a meta-analysis.

Authors:  A S Detsky; J P Baker; K O'Rourke; V Goel
Journal:  Ann Intern Med       Date:  1987-08       Impact factor: 25.391

7.  The effect of nutritional support on outcome from severe head injury.

Authors:  B Young; L Ott; D Twyman; J Norton; R Rapp; P Tibbs; D Haack; B Brivins; R Dempsey
Journal:  J Neurosurg       Date:  1987-11       Impact factor: 5.115

8.  Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery.

Authors:  P Stehle; J Zander; N Mertes; S Albers; C Puchstein; P Lawin; P Fürst
Journal:  Lancet       Date:  1989-02-04       Impact factor: 79.321

9.  Estimation of body composition from bioelectric impedance of body segments.

Authors:  R N Baumgartner; W C Chumlea; A F Roche
Journal:  Am J Clin Nutr       Date:  1989-08       Impact factor: 7.045

10.  Stimulation of T cell immunity by arginine enhances survival in peritonitis.

Authors:  H P Madden; R J Breslin; H L Wasserkrug; G Efron; A Barbul
Journal:  J Surg Res       Date:  1988-06       Impact factor: 2.192

View more
  1 in total

1.  Enterocutaneous fistula: a reconstructive dilemma.

Authors:  C O Duncan; M J Earley; P R O'Connell
Journal:  Ir J Med Sci       Date:  1998 Jan-Mar       Impact factor: 1.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.